Osteochondritis Dissecans

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2012-06-26
Clinical Trial Update: Use of Demineralised Bone Matrix (DBX) in Osteochondritis Dissecans (OCD) [Phase 4]
Phase 4 trial evaluating Demineralised Bone Matrix (DBX) for Osteochondritis Dissecans has been withdrawn.